Home Nucleus Biotechnology Belgium Next Generation Sequencing (NGS) Market to 2032

Belgium Next Generation Sequencing (NGS) Market to 2032

Overview

The Belgium Next Generation Sequencing (NGS) Market is expected to reach a 754.85 USD Billion by 2032 and is projected to grow at a CAGR of 19.76% from 2025 to 2032.

Revenue, 2024 (USD Billion)
267.45
Forecast, 2032 (USD Billion)
754.85
CAGR, 2024 - 2032
19.76%
Report Coverage
Belgium

Belgium Next Generation Sequencing (NGS) Market 2018-2032 USD Billion

Belgium Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 267.45 USD Billion
  • Projected Market Size (2032): 754.85 USD Billion
  • CAGR (2025-2032): 19.76%

Key Findings of Belgium Next Generation Sequencing (NGS) Market

  • The Belgium Next Generation Sequencing (NGS) Market was valued at 754.85 USD Billion in 2024.
  • The Belgium Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 19.76% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Precision Medicine in Application Segment accounted for the largest share of the market with a revenue of 267.45 USD Billion
  • The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 21.38% during the forecast period from 2024 to 2032.

Belgium Next Generation Sequencing (NGS) Market Scope

Belgium Next Generation Sequencing (NGS) Market Segmentation & Scope
Application
  • Others
  • Food Pathogen Screening
  • Agricultural & Animal Research
  • Diagnostics
  • Pharmaceuticals Microbiology
  • Precision Medicine
  • Drug & Biomarker Discovery
Technology
  • Others
  • Sequencing By Ligation (SBL)
  • Sequencing By Synthesis (SBS)
Product & Service
  • Instruments
  • Services
  • Consumables
End User
  • Others
  • Contract Research Organizations (CROS)
  • Clinical Laboratories
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender

Belgium Next Generation Sequencing (NGS) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 267.45 USD Billion
Market Value in 2032 754.85 USD Billion
CAGR (2025-2032) 19.76%
Historic Data 2016-2023
Market Segments Covered Application,Technology,Product & Service,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): Belgium, leading in terms of revenue 267.45 USD Billion in 2024
    • Key Country: Belgium, leading in terms of revenue with value of 267.45 USD Billion in 2024.

Segments and Scope

  • Belgium Next Generation Sequencing (NGS) Market to 2032, By Application
    • Precision Medicine is the largest segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a revenue of 267.45 USD Billion in the year 2024.
    • Pharmaceuticals Microbiology is the Fastest growing segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 19.76 % in forecast period 2025-2032.
  • Belgium Next Generation Sequencing (NGS) Market to 2032, By Technology
    • Sequencing By Synthesis (SBS) is the largest segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a revenue of 160.10 USD Billion in the year 2024.
    • Sequencing By Synthesis (SBS) is the Fastest growing segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.09 % in forecast period 2025-2032.
  • Belgium Next Generation Sequencing (NGS) Market to 2032, By Product & Service
    • Consumables is the largest segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a revenue of 130.95 USD Billion in the year 2024.
    • Services is the Fastest growing segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 19.52 % in forecast period 2025-2032.
  • Belgium Next Generation Sequencing (NGS) Market to 2032, By End User
    • Pharmaceutical & Biotechnology Companies is the largest segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a revenue of 100.86 USD Billion in the year 2024.
    • Pharmaceutical & Biotechnology Companies is the Fastest growing segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.94 % in forecast period 2025-2032.
  • Belgium Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a revenue of 159.00 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in Belgium Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 20.05 % in forecast period 2025-2032.

Belgium Next Generation Sequencing (NGS) Market Company Share Analysis

 
Company Name Company Share Analysis
Merck KGaA
Thermo Fisher Scientific Inc.
QIAGEN
Charles River Laboratories
Belgium Next Generation Sequencing (NGS) Market Company Share Analysis

Belgium Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion

Belgium Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion

Belgium Next Generation Sequencing (NGS) Market Company Profiling

Belgium Next Generation Sequencing (NGS) Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market
Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
North America Cell And Gene Therapy Thawing Equipment Market
Europe Cell And Gene Therapy Thawing Equipment Market
Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
Argentina Cell And Gene Therapy Thawing Equipment Market
Australia Cell And Gene Therapy Thawing Equipment Market
Belgium Cell And Gene Therapy Thawing Equipment Market
Brazil Cell And Gene Therapy Thawing Equipment Market
Canada Cell And Gene Therapy Thawing Equipment Market
Frequently Asked Questions
The Belgium Next Generation Sequencing (NGS) Market is segmented based on Segmentation Application,Technology,Product & Service,End User,Distribution Channel.
Belgium Next Generation Sequencing (NGS) Market was valued at USD 267.45(Revenue in USD Billion) in 2020.
Belgium Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 19.76% during the forecast period of 2024 to 2032.
The Precision Medicine segment is expected to dominate the Belgium Next Generation Sequencing (NGS) Market, holding a largest market share of 267.45 USD Billion in 2024

Coming Soon....

Belgium Next Generation Sequencing (NGS) Market Scope

Belgium Next Generation Sequencing (NGS) Market Segmentation & Scope
Application
  • Others
  • Food Pathogen Screening
  • Agricultural & Animal Research
  • Diagnostics
  • Pharmaceuticals Microbiology
  • Precision Medicine
  • Drug & Biomarker Discovery
Technology
  • Others
  • Sequencing By Ligation (SBL)
  • Sequencing By Synthesis (SBS)
Product & Service
  • Instruments
  • Services
  • Consumables
End User
  • Others
  • Contract Research Organizations (CROS)
  • Clinical Laboratories
  • Hospitals & Clinics
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tender
Frequently Asked Questions
The Belgium Next Generation Sequencing (NGS) Market is segmented based on Segmentation Application,Technology,Product & Service,End User,Distribution Channel.
Belgium Next Generation Sequencing (NGS) Market was valued at USD 267.45(Revenue in USD Billion) in 2020.
Belgium Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 19.76% during the forecast period of 2024 to 2032.
The estimated market value of the Belgium Next Generation Sequencing (NGS) Market for final year is USD 754.85 (USD Billion).

Belgium Next Generation Sequencing (NGS) Market Company Profiling

Belgium Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The Belgium Next Generation Sequencing (NGS) Market is segmented based on Segmentation Application,Technology,Product & Service,End User,Distribution Channel.
Belgium Next Generation Sequencing (NGS) Market was valued at USD 267.45(Revenue in USD Billion) in 2020.
Belgium Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 19.76% during the forecast period of 2024 to 2032.
The estimated market value of the Belgium Next Generation Sequencing (NGS) Market for final year is USD 754.85 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.